Alice Boilève, Loïc Verlingue, Antoine Hollebecque, Valérie Boige, Michel Ducreux, David Malka. Expert Opin Investig Drugs 2021
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
100
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.
Apinya Jusakul, Ioana Cutcutache, Chern Han Yong, Jing Quan Lim, Mi Ni Huang, Nisha Padmanabhan, Vishwa Nellore, Sarinya Kongpetch, Alvin Wei Tian Ng, Ley Moy Ng,[...]. Cancer Discov 2017
Apinya Jusakul, Ioana Cutcutache, Chern Han Yong, Jing Quan Lim, Mi Ni Huang, Nisha Padmanabhan, Vishwa Nellore, Sarinya Kongpetch, Alvin Wei Tian Ng, Ley Moy Ng,[...]. Cancer Discov 2017
100
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Ghassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy,[...]. Lancet Oncol 2020
Ghassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy,[...]. Lancet Oncol 2020
75
Genomic spectra of biliary tract cancer.
Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki, Tomoki Shirota, Asmaa Elzawahry, Mamoru Kato, Natsuko Hama, Fumie Hosoda, Tomoko Urushidate, Shoko Ohashi,[...]. Nat Genet 2015
Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki, Tomoki Shirota, Asmaa Elzawahry, Mamoru Kato, Natsuko Hama, Fumie Hosoda, Tomoko Urushidate, Shoko Ohashi,[...]. Nat Genet 2015
75
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B Andersen, Pietro Invernizzi, Guro E Lind, Trine Folseraas, Stuart J Forbes, Laura Fouassier,[...]. Nat Rev Gastroenterol Hepatol 2016
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B Andersen, Pietro Invernizzi, Guro E Lind, Trine Folseraas, Stuart J Forbes, Laura Fouassier,[...]. Nat Rev Gastroenterol Hepatol 2016
75
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Ghassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, Robin K Kelley, Sam J Lubner, Jorge Adeva, James M Cleary, Daniel V Catenacci, Mitesh J Borad, John Bridgewater,[...]. Lancet Oncol 2020
Ghassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, Robin K Kelley, Sam J Lubner, Jorge Adeva, James M Cleary, Daniel V Catenacci, Mitesh J Borad, John Bridgewater,[...]. Lancet Oncol 2020
75
New Horizons for Precision Medicine in Biliary Tract Cancers.
Juan W Valle, Angela Lamarca, Lipika Goyal, Jorge Barriuso, Andrew X Zhu. Cancer Discov 2017
Juan W Valle, Angela Lamarca, Lipika Goyal, Jorge Barriuso, Andrew X Zhu. Cancer Discov 2017
75
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
75
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.
Mina Komuta, Olivier Govaere, Vincent Vandecaveye, Jun Akiba, Werner Van Steenbergen, Chris Verslype, Wim Laleman, Jacques Pirenne, Raymond Aerts, Hirohisa Yano,[...]. Hepatology 2012
Mina Komuta, Olivier Govaere, Vincent Vandecaveye, Jun Akiba, Werner Van Steenbergen, Chris Verslype, Wim Laleman, Jacques Pirenne, Raymond Aerts, Hirohisa Yano,[...]. Hepatology 2012
50
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.
Arndt Vogel, Stefan Kasper, Michael Bitzer, Andreas Block, Marianne Sinn, Henning Schulze-Bergkamen, Markus Moehler, Nicole Pfarr, Volker Endris, Benjamin Goeppert,[...]. Eur J Cancer 2018
Arndt Vogel, Stefan Kasper, Michael Bitzer, Andreas Block, Marianne Sinn, Henning Schulze-Bergkamen, Markus Moehler, Nicole Pfarr, Volker Endris, Benjamin Goeppert,[...]. Eur J Cancer 2018
50
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, Jun Suk Kim, Hye Jin Choi, Myung Ah Lee, Joung Soon Jang, Hei Cheul Jeung, Jung Hun Kang, Hyun Woo Lee,[...]. Lancet Oncol 2012
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, Jun Suk Kim, Hye Jin Choi, Myung Ah Lee, Joung Soon Jang, Hei Cheul Jeung, Jung Hun Kang, Hyun Woo Lee,[...]. Lancet Oncol 2012
50
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J W Valle, I Borbath, S A Khan, F Huguet, T Gruenberger, D Arnold. Ann Oncol 2016
J W Valle, I Borbath, S A Khan, F Huguet, T Gruenberger, D Arnold. Ann Oncol 2016
50
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.
Benjamin R Kipp, Jesse S Voss, Sarah E Kerr, Emily G Barr Fritcher, Rondell P Graham, Lizhi Zhang, W Edward Highsmith, Jun Zhang, Lewis R Roberts, Gregory J Gores,[...]. Hum Pathol 2012
Benjamin R Kipp, Jesse S Voss, Sarah E Kerr, Emily G Barr Fritcher, Rondell P Graham, Lizhi Zhang, W Edward Highsmith, Jun Zhang, Lewis R Roberts, Gregory J Gores,[...]. Hum Pathol 2012
50
Molecular profile of BRCA-mutated biliary tract cancers.
Gilbert Spizzo, Alberto Puccini, Joanne Xiu, Richard M Goldberg, Axel Grothey, Anthony F Shields, Sukeshi Patel Arora, Moh'd Khushman, Mohamed E Salem, Francesca Battaglin,[...]. ESMO Open 2020
Gilbert Spizzo, Alberto Puccini, Joanne Xiu, Richard M Goldberg, Axel Grothey, Anthony F Shields, Sukeshi Patel Arora, Moh'd Khushman, Mohamed E Salem, Francesca Battaglin,[...]. ESMO Open 2020
50
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D Taylor-Robinson, Shahid A Khan. J Hepatol 2020
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D Taylor-Robinson, Shahid A Khan. J Hepatol 2020
50
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Daniela Sia, Yujin Hoshida, Augusto Villanueva, Sasan Roayaie, Joana Ferrer, Barbara Tabak, Judit Peix, Manel Sole, Victoria Tovar, Clara Alsinet,[...]. Gastroenterology 2013
Daniela Sia, Yujin Hoshida, Augusto Villanueva, Sasan Roayaie, Joana Ferrer, Barbara Tabak, Judit Peix, Manel Sole, Victoria Tovar, Clara Alsinet,[...]. Gastroenterology 2013
50
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Yasuhito Arai, Yasushi Totoki, Fumie Hosoda, Tomoki Shirota, Natsuko Hama, Hiromi Nakamura, Hidenori Ojima, Koh Furuta, Kazuaki Shimada, Takuji Okusaka,[...]. Hepatology 2014
Yasuhito Arai, Yasushi Totoki, Fumie Hosoda, Tomoki Shirota, Natsuko Hama, Hiromi Nakamura, Hidenori Ojima, Koh Furuta, Kazuaki Shimada, Takuji Okusaka,[...]. Hepatology 2014
50
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Juan Valle, Harpreet Wasan, Daniel H Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Tim Iveson, Sharon Hughes, Stephen P Pereira,[...]. N Engl J Med 2010
Juan Valle, Harpreet Wasan, Daniel H Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Tim Iveson, Sharon Hughes, Stephen P Pereira,[...]. N Engl J Med 2010
50
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.
Chirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, Andrzej Taranta, Steven Shema, Prson Gautam, Julien Calderaro, Andrew Barbour, Chiara Raggi, Krister Wennerberg,[...]. Hepatology 2018
Chirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, Andrzej Taranta, Steven Shema, Prson Gautam, Julien Calderaro, Andrew Barbour, Chiara Raggi, Krister Wennerberg,[...]. Hepatology 2018
50
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha Shah, Ronnie Shapira-Frommer, Kazuhiko Nakagawa, Hyun Cheol Chung, Hedy L Kindler, Jose A Lopez-Martin, Wilson H Miller,[...]. Lancet Oncol 2020
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha Shah, Ronnie Shapira-Frommer, Kazuhiko Nakagawa, Hyun Cheol Chung, Hedy L Kindler, Jose A Lopez-Martin, Wilson H Miller,[...]. Lancet Oncol 2020
50
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies.
Sarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung, Adnan Nagrial, Robin K Kelley, Willeke Ros, Antoine Italiano, Kazuhiko Nakagawa,[...]. Int J Cancer 2020
Sarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung, Adnan Nagrial, Robin K Kelley, Willeke Ros, Antoine Italiano, Kazuhiko Nakagawa,[...]. Int J Cancer 2020
50
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
50
Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.
Angela Lamarca, Jorge Barriuso, Mairéad G McNamara, Juan W Valle. J Hepatol 2020
Angela Lamarca, Jorge Barriuso, Mairéad G McNamara, Juan W Valle. J Hepatol 2020
50
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Jesus M Banales, Jose J G Marin, Angela Lamarca, Pedro M Rodrigues, Shahid A Khan, Lewis R Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B Andersen, Chiara Braconi,[...]. Nat Rev Gastroenterol Hepatol 2020
Jesus M Banales, Jose J G Marin, Angela Lamarca, Pedro M Rodrigues, Shahid A Khan, Lewis R Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B Andersen, Chiara Braconi,[...]. Nat Rev Gastroenterol Hepatol 2020
50
Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies.
Jennifer Y Ju, Megan E Dibbern, Mani S Mahadevan, Jinbo Fan, Paul R Kunk, Edward B Stelow. Am J Clin Pathol 2020
Jennifer Y Ju, Megan E Dibbern, Mani S Mahadevan, Jinbo Fan, Paul R Kunk, Edward B Stelow. Am J Clin Pathol 2020
50
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan,[...]. Future Oncol 2020
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan,[...]. Future Oncol 2020
50
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.
Ian M Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C Newton, Huiling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn. Cancer Discov 2021
Ian M Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C Newton, Huiling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn. Cancer Discov 2021
50
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
Vincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, Christian Cotsoglou, William P Harris, Nevena Damjanov, Gianluca Masi, Lorenza Rimassa, Nicola Personeni, Fadi Braiteh,[...]. Br J Cancer 2019
Vincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, Christian Cotsoglou, William P Harris, Nevena Damjanov, Gianluca Masi, Lorenza Rimassa, Nicola Personeni, Fadi Braiteh,[...]. Br J Cancer 2019
50
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Vikneswari Rajasegaran, Tse Hui Lim, Kiat Hon Lim, Su Pin Choo, Simona Dima,[...]. JCO Glob Oncol 2020
Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Vikneswari Rajasegaran, Tse Hui Lim, Kiat Hon Lim, Su Pin Choo, Simona Dima,[...]. JCO Glob Oncol 2020
50
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
50
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Milind Javle, Maeve Lowery, Rachna T Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J Borad, Ramesh K Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla,[...]. J Clin Oncol 2018
Milind Javle, Maeve Lowery, Rachna T Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J Borad, Ramesh K Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla,[...]. J Clin Oncol 2018
50
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
Antonella De Luca, Riziero Esposito Abate, Anna Maria Rachiglio, Monica Rosaria Maiello, Claudia Esposito, Clorinda Schettino, Francesco Izzo, Guglielmo Nasti, Nicola Normanno. Int J Mol Sci 2020
Antonella De Luca, Riziero Esposito Abate, Anna Maria Rachiglio, Monica Rosaria Maiello, Claudia Esposito, Clorinda Schettino, Francesco Izzo, Guglielmo Nasti, Nicola Normanno. Int J Mol Sci 2020
50
Targeting FGFR inhibition in cholangiocarcinoma.
Lipika Goyal, Sarinya Kongpetch, Valerie E Crolley, John Bridgewater. Cancer Treat Rev 2021
Lipika Goyal, Sarinya Kongpetch, Valerie E Crolley, John Bridgewater. Cancer Treat Rev 2021
50
Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
Judith Meza-Junco, Aldo J Montano-Loza, Vickie E Baracos, Carla M M Prado, Vincent G Bain, Crystal Beaumont, Nina Esfandiari, Jessica R Lieffers, Michael B Sawyer. J Clin Gastroenterol 2013
Judith Meza-Junco, Aldo J Montano-Loza, Vickie E Baracos, Carla M M Prado, Vincent G Bain, Crystal Beaumont, Nina Esfandiari, Jessica R Lieffers, Michael B Sawyer. J Clin Gastroenterol 2013
25
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari, Giovanni Brandi. Medicines (Basel) 2020
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari, Giovanni Brandi. Medicines (Basel) 2020
25
Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan.
Sergey V Silkin, Sergey S Startsev, Marina E Krasnova, Grigory A Raskin, Natalia V Mitiushkina, Aglaya G Iyevleva, Anna P Sokolenko, Evgeny N Imyanitov. J Gastrointest Cancer 2016
Sergey V Silkin, Sergey S Startsev, Marina E Krasnova, Grigory A Raskin, Natalia V Mitiushkina, Aglaya G Iyevleva, Anna P Sokolenko, Evgeny N Imyanitov. J Gastrointest Cancer 2016
25
A population based analysis of prognostic factors in advanced biliary tract cancer.
Renata D'Alpino Peixoto, Daniel Renouf, Howard Lim. J Gastrointest Oncol 2014
Renata D'Alpino Peixoto, Daniel Renouf, Howard Lim. J Gastrointest Oncol 2014
25
Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.
Lu Wu, Diamantis I Tsilimigras, Ayesha Farooq, J Madison Hyer, Katiuscha Merath, Anghela Z Paredes, Rittal Mehta, Kota Sahara, Feng Shen, Timothy M Pawlik. J Surg Oncol 2019
Lu Wu, Diamantis I Tsilimigras, Ayesha Farooq, J Madison Hyer, Katiuscha Merath, Anghela Z Paredes, Rittal Mehta, Kota Sahara, Feng Shen, Timothy M Pawlik. J Surg Oncol 2019
25
Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Timothy Kendall, Joanne Verheij, Eugenio Gaudio, Matthias Evert, Maria Guido, Benjamin Goeppert, Guido Carpino. Liver Int 2019
Timothy Kendall, Joanne Verheij, Eugenio Gaudio, Matthias Evert, Maria Guido, Benjamin Goeppert, Guido Carpino. Liver Int 2019
25
CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications.
Kamile Gul, Sevinc Nas, Didem Ozdemir, Mehmet Gumus, Reyhan Ersoy, Bekir Cakir. Am J Med Sci 2011
Kamile Gul, Sevinc Nas, Didem Ozdemir, Mehmet Gumus, Reyhan Ersoy, Bekir Cakir. Am J Med Sci 2011
25
Regulation and Function of the PD-L1 Checkpoint.
Chong Sun, Riccardo Mezzadra, Ton N Schumacher. Immunity 2018
Chong Sun, Riccardo Mezzadra, Ton N Schumacher. Immunity 2018
25
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
D Yoshikawa, H Ojima, M Iwasaki, N Hiraoka, T Kosuge, S Kasai, S Hirohashi, T Shibata. Br J Cancer 2008
D Yoshikawa, H Ojima, M Iwasaki, N Hiraoka, T Kosuge, S Kasai, S Hirohashi, T Shibata. Br J Cancer 2008
25
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
25
25
Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine.
Arturo Loaiza-Bonilla, Erica Clayton, Emma Furth, Mark O'Hara, Jennifer Morrissette. Ecancermedicalscience 2014
Arturo Loaiza-Bonilla, Erica Clayton, Emma Furth, Mark O'Hara, Jennifer Morrissette. Ecancermedicalscience 2014
25
Molecular Pathogenesis of Cholangiocarcinoma.
Peter L Labib, George Goodchild, Stephen P Pereira. BMC Cancer 2019
Peter L Labib, George Goodchild, Stephen P Pereira. BMC Cancer 2019
25
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.
Francesca V Negri, Barbara Dal Bello, Camillo Porta, Nicoletta Campanini, Sandro Rossi, Carmine Tinelli, Guido Poggi, Gabriele Missale, Silvia Fanello, Stefania Salvagni,[...]. Liver Int 2015
Francesca V Negri, Barbara Dal Bello, Camillo Porta, Nicoletta Campanini, Sandro Rossi, Carmine Tinelli, Guido Poggi, Gabriele Missale, Silvia Fanello, Stefania Salvagni,[...]. Liver Int 2015
25
Detection of circulating tumor cells in cancers of biliary origin.
Omar Al Ustwani, Dan Iancu, Rabi Yacoub, Renuka Iyer. J Gastrointest Oncol 2012
Omar Al Ustwani, Dan Iancu, Rabi Yacoub, Renuka Iyer. J Gastrointest Oncol 2012
25
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Leigh Marcus, Steven J Lemery, Patricia Keegan, Richard Pazdur. Clin Cancer Res 2019
Leigh Marcus, Steven J Lemery, Patricia Keegan, Richard Pazdur. Clin Cancer Res 2019
25
Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.
Halim Charbel, Firas H Al-Kawas. Curr Gastroenterol Rep 2011
Halim Charbel, Firas H Al-Kawas. Curr Gastroenterol Rep 2011
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.